Dr. Kristin Fabre is the deputy chief scientist for NASA’s Human Research Program (HRP). In this role, she helps set HRP’s scientific strategy on research that pursues the best methods and technologies to supports safe, productive human space travel. Through science conducted in laboratories, ground-based analogs, and the International Space Station, HRP scrutinizes how spaceflight affects human bodies and behaviors. Dr. Fabre's expertise drives HRP further on its quest to innovate ways that keep astronauts healthy and mission-ready as space travel expands to the Moon, Mars, and beyond.

Before joining HRP, Dr. Fabre served as chief scientist at the Translational Research Institute for Space Health (TRISH). There, she led the effort to invest in high-risk, high-reward research and technology for space exploration. She worked with NASA, the industry, and academia as TRISH stakeholders to adopt and implement deliverables.

Prior to TRISH, Dr. Fabre served as the micro-physiological systems lead at the pharmaceutical company AstraZeneca. Before AstroZeneca, she worked as the scientific program manager for the Organs-on-Chips initiative at the National Center for Advancing Translational Sciences of the National Institute of Health (NIH).

She received her bachelor’s degree in biology from the University of Wyoming, followed by her master’s degree and doctorate degree in cell and molecular biology from Colorado State University. She then served as a postdoctoral fellow in the radiation biology branch at the NIH National Cancer Institute.

SXSW, Space, NASA, Cancer, Science, Technology, Molecular Biology, Texas, Houston, TX,